About this Event
UHN Collaborative Centre for Drug Discovery (C2D2) Launch Symposium
Join us for the official launch of the Collaborative Centre for Drug Discovery (C2D2)—a new initiative focused on advancing disease-driven drug discovery at UHN.
This symposium brings together leading researchers, clinicians, and partners from across UHN, the Structural Genomics Consortium, and the broader Toronto research community.
Why attend
- Hear from prominent researchers and clinicians across UHN
- Explore new opportunities in translational and small-molecule drug discovery
- Connect with researchers and clinicians across disciplines
- Engage in discussions shaping the future of therapeutic discovery at UHN
Event details
Date: June 9, 2026
Time: 8:00 a.m. – 4:00 p.m.
Location: MaRS Auditorium, 101 College St, Toronto
Registration: Free (advance registration required)
Food & Beverage will be provided.
About C2D2
The Collaborative Centre for Drug Discovery (C2D2) is a synergistic collaboration between SGC-Toronto and UHN Therapeutics that aims to translate discoveries in disease biology into actionable drug targets. By combining expertise in small-molecule development with clinical and research collaboration, C2D2 enables new therapeutic strategies and accelerates promising discoveries toward impact. Visit our website for more details: https://www.uhnresearch.ca/service/uhn-collaborative-centre-for-drug-discovery
Launch Symposium comments and inquiries can be sent to [email protected].
Event Venue & Nearby Stays
MaRS Discovery District, 101 College Street, Toronto, Canada
CAD 0.00
